Alessandro Sanitin/LinkedIn
Apr 7, 2026, 13:50
Alessandro Santin Discusses New Targets in Rare Endometrial Disease – Yale Obstetrics, Gynecology and Reproductive Sciences
Yale Obstetrics, Gynecology and Reproductive Sciences shared a post on LinkedIn:
” ‘It’s only when you acquire the type of deep knowledge in the molecular characteristic that you may really identify potential targets,’ says our own Yale Ob/Gyn’s Alessandro Sanitin, MD.
In an interview with Contemporary OB/GYN, Dr. Santin discusses his investigation of new treatments for rare endometrial disease.
Read and/or listen here.”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Oct 29, 2026, 16:22Aysha O’Connor: One of the Hardest Parts of My Own Fertility Journey Was Loneliness…
-
Oct 29, 2026, 16:15Chaithra S K: Preimplantation Genetic Testing Still Requires an Embryo Biopsy
-
Oct 29, 2026, 16:11Filipina Woman’s Journey of Strength, Hope, and Finding Balance While Living with PCOS – PCOS Millennials
-
Oct 29, 2026, 15:58Eric Lameignere: Can DNA Fragmentation in Cumulus Cells Predict ICSI Outcomes?
-
Oct 29, 2026, 15:50Saadat Hassan: Sperm Function Testing – Can Advanced Diagnostics Guide IVF and ICSI Selection?
-
Oct 29, 2026, 15:34Sara Spiro: Celebrating the Stories Members Have Trusted With at Maven Clinic – Here Is Mine
-
Oct 29, 2026, 15:31Dina Ibrahem: 0 Motility, 1 Critical Decision
-
Oct 29, 2026, 15:28AI and Automation in Fertility and Genomics: Pipeline or Pipe Dream? – ARCS
-
Oct 29, 2026, 15:26Michael Schindler: Large Networks or Small Centers – Who Delivers Better Care?